Androgen signaling inhibition in prostate cancer is achieved by two primary methods: (1) by decreasing the androgen production, and (2) by inhibiting and modulating the activity of the androgen receptor intratumorally [21]. This evidence concerns the gene AR and prostate carcinoma.